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Abstract
Curcumin attracts worldwide scientific interest due to its anti-proliferative and apoptosis inducing effects on different tumor
cells at concentrations ranging from 10 to 150 mM (3.7–55 mg/ml). Unfortunately, because of a low oral bioavailability, only
low and pharmacologically ineffective serum levels are achievable. In this study, an alternative treatment concept consisting
of low concentration curcumin (0.2–5 mg/ml) and irradiation with UVA or visible light (VL) has been tested. The experimental
results show clearly that this treatment decreases the proliferation and the viability of human melanoma cells while the cell
membrane integrity remains intact. We identified the onset of apoptosis characterized by typical markers such as active
caspases 8, 9 and 3 as well as DNA fragmentation accompanied by the loss of cell adhesion. The mitochondrial apoptosis
signaling pathway is predominant due to an early activation of caspase-9. The present data indicate a higher efficacy of a
combination of curcumin and VL than curcumin and UVA. Reduced effects as a result of light absorption by heavily
pigmented skin are unlikely if VL is used. These results indicate that a combination of curcumin and light irradiation may be
a useful additional therapy in the treatment of malignant disease.
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Introduction
Curcumin is an intensive orange-yellow colored, phenolic
pigment found in the rhizome of the Curcuma longa plant. In the
form of yellow powder, curcuma longa has been widely used as a
spice and medicinal plant in traditional Asian medicine [1,2].
Curcumin has attracted worldwide scientific interest regarding its
anti-inflammatory, anti-oxidative and, as frequently demonstrated,
anti-proliferative, and apoptosis-inducing effects on different
tumor cells [2–4]. Concerning pigment producing cells and tumor
cells, the influence of curcumin on pigmentation may be of special
interest. Pigment synthesis is a complex regulated process
involving many different factors acting in both a receptor-
dependent and -independent manner via different signaling
pathways. The complex mechanism of melanogenesis and its
regulation has been extensively reviewed by Slominski et al. [5]
Curcumin is known to inhibit melanin synthesis by down-
regulation of microphthalmia associated transcription factor
(MITF) and its downstream signal pathway through activation of
PI3/AKT and the MAP-kinases ERK or p38 [6,7]. In particular,
the minimal side-effects of curcumin even at high oral adminis-
tered doses of up to 8 g per day make it an interesting compound
for treating malignant diseases [3]. Unfortunately, the effective
usage of curcumin is hampered by its extensive metabolism by
cytochromes P-450 (CYPs), UDP-glucuronosyltransferase (UGT),
and sulfotransferase (SULT) [8]. Even a high-dose oral adminis-
tration of curcumin leads only to low serum levels of,2 mM
(,0,7 mg/ml) for a few hours [3] offering no significant
pharmacological effects [9–12]. In this context, the discovery of
a phototoxic activity of curcumin by Tonnesen et al. [13] and
Dahl et al. [14,15] is of particular interest as low concentrations
are shown to be effective in achieving anti-proliferative and
cytotoxic effects on bacteria and mammalian cells.
The structure of curcumin contains several functional groups
which are pivotal for its biologic activity comprising two phenol
groups, each with monosubstituated methoxy and hydroxyl
groups, which are bound together by an aliphatic carbohydrate
chain with a diketone group [1,16]. The keto groups of the
molecule exhibit potent electrophilic characteristics [2] but also
the methoxy groups of curcumin are important for its anti-
oxidative properties [1]. A central role for the apoptosis inducing
effect of curcumin is played by the electrophilic double bonds of
the carbohydrate chain that can be attacked by a nucleophilic
group in an addition-reaction forming a covalent adduct [17,18].
Furthermore, the lipophilic curcumin interacts with hydrophobic
protein domains, dissolves in cellular lipid bilayers and disturbs the
fluidity leading to a change in the conformation and function of
integral membrane proteins [2,19,20]. Overall, it can be assumed
that because of these multiple biochemical properties of curcumin,
a major molecular mechanism could not be identified so far [2].
Despite the still unknown exact biochemical mode of action of
curcumin, there are many publications available describing its
effects on cellular signaling cascades. The first step is a cell cycle
arrest at the G2/M transition point, but also at transition points
G0/G1- and G1/S, resulting in inhibition of cell proliferation [21–
24]. An increase in curcumin dose (.10 mM) and incubation time
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30]. Most studies describe the curcumin-induced apoptosis as
caspase-dependent with a documented activation of effector
caspase-3 [4,9,11,25–29,31–32]. Several researchers came to
different conclusions regarding the role of the apoptotic pathways:
some suggest the mitochondrial pathway [4,28,32], some the
extrinsic pathway via caspase-8 [34,35] and others both pathways
as being predominant [10,36,37]. There are also some studies
suggesting a predominant role of caspase-independent signaling
pathways in curcumin-induced apoptosis [38,39]. It seems that the
induction of apoptosis by curcumin is dependent on the cell line
used and on the interaction of curcumin with several proliferation
associated factors. Curcumin inhibits the kinases PKA and PKC,
the receptor tyrosine kinase EGFR and the transcription factors
NFkB and c-myc (summarized in [3,26]). Taken together, this
leads to a down-regulation of anti-apoptotic signaling molecules
such as Bcl-2, Bcl-XL, cIAP, survivin, TRAF1 and cyclin D1 in
downstream pathways [25,32]. The impairment of many apoptot-
ic factors based on the multiple biochemical properties of
curcumin may be responsible for apoptosis induction in variably
differentiated cells [2,3,25].
Based on the observation that low concentrations of curcumin
combined with light irradiation (UVA and VL) induce apoptosis in
human keratinocytes [12], we tested the effects of such a combined
treatment on human melanoma cells.
Materials and Methods
Cell culture
In this study, melanoma cancer cell lines G-361 and A375 were
used. G-361, and A375 tumor cells were obtained from the
American Type Culture Collection. G-361 cells were grown in
RPMI 1640 medium (Gibco, Karlsruhe, Germany) with 10%
FBS, 1% P/S solution and additional 1% L-glutamine solution
(Invitrogen, Karlsruhe, Germany). The A375 cell culture medium
contained Dulbecco Modified Eagle Medium with 4.5 g/l D-
Glucose (DMEMhigh) (Gibco, Karlsruhe, Germany), 10% FBS
and 1% P/S solution. All cells were cultured at 37uCi na
humidified atmosphere containing 5% CO2 in case of G-361 cells
and 7.5% CO2 in case of A375 cells.
Treatment
All experiments were performed under sterile conditions; all
media used were warmed to 37uC. HEPES buffer was added to
the culture media needed for experiments (40 mM), the pH values
remained constant at 6.8. A curcumin stock solution was prepared
by dissolving 30 mg of curcumin (Sigma-Aldrich, Taufkirchen,
Germany) in 1 ml DMSO. Serial dilutions of curcumin were
prepared from the stock solution using culture medium or
phosphate buffered saline (PBS). The highest final concentration
of DMSO was 0.02% which is about 50 fold lower than the
described toxic concentrations [40] and did not show any
detectable effect on cell behavior (not shown). Cells were detached
from the culture flasks using trypsin/EDTA and seeded into the
required test vessel. After 24 hours, the adherent cells were
incubated with curcumin-containing medium for 1 hour. Prior to
irradiation the medium was replaced by PBS to prevent a build-up
of reactive photochemical products. Cells were then irradiated
with UVA (315–400 nm, cumulative dose 1 J/cm
2, Waldmann,
Villingen-Schwenningen, Germany) or visible light (5500 lx,
10640 W lamps, distance 45 cm, emission spectrum: 400–
550 nm, cumulative dose 1.65 J/cm
2; Philips GmbH, Hamburg,
Germany). Under the described conditions the visible light source
emitted a small UVA part with a cumulative dose of 0.03 J/cm
2
measured with an UV-meter (Waldmann, Villingen-Schwennin-
gen, Germany). A rise in temperature was excluded by continuous
measurements with a mercury thermometer. Parallel to the
irradiation, identically treated controls were kept in the dark.
Thereafter, culture medium was added and the test vessel kept in
an incubator until the analysis 4–48 hours later. In some
experiments synthetic melanin was added to the culture medium
to check whether this pigment lowers the light intensity by
absorption. For this purpose a stock solution of melanin was
prepared by dissolving 500 mg/ml melanin (Sigma, Taufkirchen,
Germany) in PBS at 95uC for 6 hrs. After cooling to 37uC the used
concentrations were generated by diluting the stock solution with
culture medium.
Cell proliferation, viability and cytotoxicity
The proliferation rate was measured using the cell proliferation
BrdU ELISA Kit (Roche Diagnostics, Penzberg, Germany) and
quantification of cell viability was conducted by the Alamar Blue
test (AbD Serotec, Oxford, UK). To determine the toxicity of the
treatment leading to cell lysis the cytotoxicity detection kit (Roche
Diagnostics, Mannheim, Germany) was used. Cells were seeded in
96-well microtiter plates with a density of approximately 1610
4
cells/well for viability and proliferation tests and 1.5610
4 cells/
well for cytotoxicity tests. 24 hours later cells were treated as
described; the range of curcumin concentrations used was 0.2 to
2 mg/ml (0.68–5.43 mM).
Cell proliferation BrdU ELISA. To determine the DNA
replication rate, 5-bromo-20-deoxyuridine (BrdU) was added to
the cells immediately after irradiation. 24 hours later the cells were
fixed and peroxidase-coupled BrdU-antibodies were added to
form BrdU-bound immune complexes. Next, the peroxidase
substrate tetramethylbenzidine was added; the resulting color
change was measured using an ELISA reader (Expert 96, ASYS,
Eugendorf, Germany; 450 nm).
Alamar Blue test. Analysis started after the final incubation
period of 24 hours by replacing the medium with PBS and
addition of Alamar Blue reagent (10%). The reduction of the blue
dye resazurin to the red fluorescent resorufin - as an equivalent to
the mitochondrial metabolic activity - was measured after 2 hours
using a CytoFluor fluorescence reader (series 4000, PerSeptive
Biosystems, Framingham, MA; excitation 530 nm, emission
620 nm).
Cytotoxicity detection. Cells of the positive control were
treated with 1% Triton-x-100. All other cells were treated as
described above. After the final incubation period of 24 hours,
cell-free supernatants containing lactate dehydrogenase from lysed
cells were obtained. The added NAD
+ solution was reduced
during the lactate dehydrogenase reaction to NADH/H
+, which
changed the yellow tetrazolium salt to a red-colored formazan salt.
The resulting color change was measured using an ELISA reader
(Expert 96, ASYS; 490 nm).
Apoptosis
Central characteristics of apoptosis are the DNA fragmentation
into 180 base pair long multimeres and the caspase activation. To
quantify the fragmentation rate the Cell Death Detection ELISA
(CDD) (Roche, Mannheim, Germany) was used. Caspase activa-
tion was documented by the Western blot technique. For CDD,
cells were seeded in 96-well microtiter plates with a density of
approximately 1610
4 cells/well. For western blot analysis cells
were seeded in three-well multidishes (1.25610
6 cells/well). 4–
12 hours later cells were treated as described. The curcumin
concentrations used ranged from 0.2 to 5 mg/ml (0.68–13.57 mM).
Effect of Curcumin and Light on Melanoma Cells
PLOS ONE | www.plosone.org 2 November 2013 | Volume 8 | Issue 11 | e79748Cell Death Detection ELISA. After the combined treatment
and 15 hours of incubation, culture medium was discarded and
the adherent cells were lysed. The lysate containing DNA
fragments was transferred on to streptavidine coated strips. Next,
an antibody enriched solution (anti-histone-biotin-antibody, anti-
DNA-peroxidase-antibody) was added leading to stable sandwich-
like immune complexes. The enzymatic conversion of the
peroxidase substrate azino-ethylbenzothiazoline-sulfonic-acid to a
colored product was measured using an ELISA reader (Expert 96,
ASYS; 405 nm).
Western blot. All cells were lysed with 36SDS sample buffer
(187.5 mM Tris–HCl at pH 6.8, 6% SDS, 30% glycerol, 150 mM
dithiothreitol, 0.3% bromphenol blue) 4 hours after the combined
treatment. The lysates were collected, sonicated and boiled for 5
minutes at 95uC. Then the samples were electrophoresed on 15%
SDS-PAGE gels in Laemmli-buffer (25 mM Tris, 250 mM
glycine, 0.5% SDS) at 120 V. Next, the proteins were transferred
to a polyvinylidene fluoride membrane (PVDF, Millipore, Bed-
ford, MA) using towbin buffer (25 mM Tris, 192 mM glycine,
10% methanol) at 50 V. Incubating for 30 min in blocking buffer
(Tris-buffered saline (pH 7.6), 0.1% Tween-20, and 5% BSA or
non-fat dry milk) blocked non-specific binding sites. Afterwards,
PVDF-membranes were covered with specific primary antibody
solutions (blocking buffer) against caspase-9 (1:3000), caspase-8
(1:3000), caspase-3 (1:3000, Cell Signaling, Beverly, USA) and
beta-actin (1:5000, Sigma-Aldrich, Taufkirchen, Germany) anti-
gens for 24 hours. Detection of the primary antibodies was carried
out using secondary, horseradish peroxidase-linked antibodies
(Cell Signaling). Finally, the antigen–antibody complexes were
visualized by a chemiluminescence detection system (LumiGlo
solution, Cell Signaling; Hyperfilm-ECL, Amersham Pharm.,
Little Chalfont, UK; PROTEC C35, Protec, Oberstenfeld,
Germany).
Statistics
For each curcumin concentration to be tested, cells were seeded
in 8 wells (cell viability, proliferation and cytotoxicity), 4 wells
(CDD detection) or 1 well (western blot). Each combination
possibility was tested separately (no irradiation, irradiation with
UVA, irradiation with visible light). Mean value and standard
deviation were calculated from 8 or 4 single values using the
program Microsoft excel. All mean values as well as the standard
deviation were expressed as a percentage of the completely
untreated control. The statistical difference of the values referred
to the untreated control was determined by the Mann-Whitney U-
test. A P-value of #0.05 was considered significant. All experi-
ments were repeated at least twice.
Results and Discussion
Impairment of DNA synthesis and viability by curcumin/
light
The absorption of light by melanin reaches its maximum at a
medium UVA range (<350–330 nm) [41], but a second
absorption maximum of curcumin is within the visible wavelength
range (420 nm) [13], therefore, a better response to the treatment
curcumin/visible light (VL) is proposed. The results of the BrdU-
based proliferation tests showed that the combined treatment
Figure 1. DNA synthesis in melanoma cells (A375 and G-361)
after treatment with curcumin and light: After incubation with
curcumin, cells were irradiated with UVA (gray bars), or visible
light (black bars), or remained light-protected (white bars). All
values were referred to the untreated control as a 100% reference. Every
bar represents the average of 8 simultaneously determined individual
values; standard deviations are shown at the top. Highly significant
reduction of DNA synthesis of the treated cells is marked with *
(P!0.001).
doi:10.1371/journal.pone.0079748.g001
Figure 2. Mitochondrial redox activity in melanoma cells (A375
and G-361) after treatment with curcumin and light: After
incubation with curcumin, cells were irradiated with UVA (gray
bars), or visible light (black bars), or remained light-protected
(white bars). All values were referred to the untreated control as a
100% reference. Every bar represents an average of 8 simultaneously
determined individual values; standard deviations are shown at the top.
Highly significant reduction of viability of the treated cells is marked
with * (P!0.001).
doi:10.1371/journal.pone.0079748.g002
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dependent manner. As shown in figure 1, the first inhibitory effects
were observed at a curcumin concentration of 0.2 mg/ml
combined with UVA or VL irradiation. The combination
curcumin/VL was more effective giving an inhibition rate of
nearly 95–98% at 1 mg/ml whereas curcumin/UVA caused a
maximum inhibition of 75–95% at 2 mg/ml. In the controls,
neither curcumin alone nor UVA or VL irradiation alone induced
a highly significant inhibition of DNA synthesis. These results
prove not only a photo-activation of curcumin but also that a
photo-activation is necessary when using low concentrations.
These findings agree with the observations of Dujic et al. [12,42]
regarding a better effect of curcumin/VL. A few recently
published studies on the effect of low curcumin doses combined
with light irradiation confirm these results as reviewed by Bernd
[43]. Data from experiments investigating the cell viability
confirmed these results (figure 2). Initial inhibitory effects started
again at a curcumin concentration of 0.2 mg/ml. We detected a
concentration-dependent impairment of mitochondrial activity
and a greater effect of curcumin and VL compared to curcumin
and UVA similar to previous experiments regarding DNA
synthesis. Curcumin or irradiation alone had no effect. Investi-
gating the effects of 3.68 mg/ml (10 mM) curcumin on cellular
signaling cascades, studies by Park et al. [21] and Liu et al. [22]
showed the induction of cell cycle arrest at the G2/M transition
point in urinary bladder carcinoma cells and in glioma cells. In our
experiments, curcumin concentrations of 2 mg/ml (5.43 mM) had
no effect on DNA synthesis (Fig. 1 and 2). The impairment of
DNA synthesis and mitochondrial redox activity by the combined
treatment implies that cells were more likely forced into cell death
than into a possible cell cycle arrest.
Role of melanin in a possible clinical application
Although the investigation of proliferation and viability of
treated cells provided no hint of an absorptive effect of melanin in
vitro, this question remained taking into account the multilayered
architecture of human skin. Using the measurements of other
groups correlating skin pigmentation and melanin concentration,
melanocytes used in other studies could be assigned to the highly
pigmented skin photo-types IV - VI [44). Due to supplying
approximately 40 supra-basal keratinocytes with melanin provided
by one melanocyte and because of aggregation of melanin to
nuclear caps in the path of light, cumulative effects in human skin
are to be expected [44,45]. To simulate a multilayered pigmen-
tation, in addition to 2 mg/ml curcumin, synthetic melanin was
added to the medium in increasing concentrations. After
irradiation with UVA or VL, cell proliferation was determined
as described previously. The results of these trials, presented in
figure 3, demonstrate a significant mitigation of the efficacy of
Figure 3. Influence of melanin on the treatment with curcumin/
light: After incubation with 2 mg/ml curcumin, a curcumin
containing PBS with increasing melanin concentrations was
added. Cells were irradiated with UVA (gray bars), or visible light (black
bars), or were light-protected (white bars) followed by the determina-
tion of the BrdU-incorporation rate. All values were referred to the
untreated control (dotted bars) as a 100% reference. Every bar
represents the average of 8 simultaneously determined individual
values; standard deviations are shown at the top. Compared to the
treated controls (0 mg/ml melanin), highly significant reduction of
proliferation inhibition is marked with * (P!0.001). Upper Part: A375;
lower part: G-361 melanoma cells.
doi:10.1371/journal.pone.0079748.g003
Figure 4. LDH release in melanoma cells (A375 and G-361) after
treatment with curcumin and light: After incubation with
curcumin, cells were irradiated with UVA (gray bars), or visible
light (black bars), or were light-protected (white bars). Cells of
the positive control were treated with 1% triton-X100 containing
medium (dashed bars). All values were referred to the positive control
as a 100% reference. Every bar represents the average of 8
simultaneously determined individual values; standard deviations are
shown at the top.
doi:10.1371/journal.pone.0079748.g004
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added. In contrast, treatment with curcumin and VL was not
affected even by high melanin concentrations, causing a maximum
inhibition of proliferation. Un-irradiated controls which either
were treated with curcumin alone or with curcumin and melanin,
were not impaired. According to the observation that additionally
added melanin reduces the effectivity of the treatment combined
with UVA, absorptive disturbances can be expected in heavily
pigmented skin. This is another reason to prefer the combination
curcumin and VL in possible clinical applications.
Membrane integrity remained unaffected
Hallmarks of necrotic cell death are loss of cell membrane
integrity and release of pro-inflammatory cytosolic components
triggering inflammation in vivo [46]. To exclude a necrotic cell
death, which is undesirable in clinical use, we investigated the
levels of the cytosolic enzyme lactate dehydrogenase (LDH) in
culture medium of treated cells. The results displayed in figure 4
show that no curcumin concentration dependent release of LDH
into the medium occurred. Also, the UVA and VL irradiation
alone did not increase the LDH levels compared to untreated
controls. In the case of G-361 cells, slightly increased LDH levels
were measured, mainly affecting those cells treated with
curcumin/VL. However, the extent of LDH release did not
compare with the induced decrease of DNA synthesis and
mitochondrial activity. Therefore, membrane damage as the
underlying mechanism after the treatment with curcumin/light
seems unlikely. These experiments were also interpreted against
the background of several experimental results showing conflicting
properties of curcumin on cellular levels of reactive oxygen species
(ROS). Rising intracellular concentrations of ROS lead to
oxidative damage of DNA, loss of enzymatic activity of proteins
and, via lipid peroxidation, to a change in membrane fluidity.
Thus, ROS can culminate in proliferation inhibition, in apoptotic
cell death, and in necrotic cell death [47,48]. Increased ROS levels
were detected in ovarian cancer cells and in human osteoblasts
when using 10–100 mM curcumin causing cell cycle arrest,
apoptosis, and necrosis [31,33]. On the other hand, Fiorillo et
al. [49] and Zhu et al. [16] showed an anti-oxidative effect of 2.5–
20 mM curcumin on human cardiac cells and on cortical neurons.
Since Dujic et al. [12] demonstrated an anti-oxidative effect of
0.2–1 mg/ml (0.68 – 2.71 mM) curcumin which neutralized ROS
generated by high dose UVA-irradiation, a dose dependent dual
role of curcumin seems likely with a turning point at 3.68–
7.36 mg/ml (10–20 mM). Therefore, a change in intracellular ROS
in our treatment protocol is presumably not the case.
Induction of DNA fragmentation by curcumin/light
According to our results and to observations of Dujic et al. [12]
that curcumin/light induces apoptosis in human keratinocytes, an
induction of apoptosis in treated melanoma cells was considered.
Hence, typical characteristics of apoptosis such as DNA fragmen-
tation and caspase activation [50] were investigated. Figure 5
demonstrates the analysis of the DNA-fragmentation rate in
treated melanoma cells showing DNA fragmentation in treated
cells in a concentration dependent manner. Using a combination
with VL, DNA fragmentation started at a curcumin concentration
of 0.2 mg/ml in melanoma cells. In the case of UVA irradiation,
DNA fragments did not occur until a curcumin concentration of
0.5 mg/ml was reached (figure 5). Again these findings reflect a
higher efficacy of curcumin and VL revealing a high susceptibility
of melanoma cells towards the combined treatment. Signal
fluctuations occurred because apoptotic cells increasingly detach
from adjacent tissue [50]. Based on the procedure of the cell death
detection ELISA (CDD-ELISA), cell culture medium was
discarded prior to cell lysis leading to loss of apoptotic bodies. In
melanoma cells, signal stagnation occurred between 10 and
24 hours. These results demonstrate a rapid onset of apoptosis and
a loss of cell adhesion in combined treated cells after irradiation.
Apoptosis induction proceeded more rapidly when a higher dose
of curcumin and VL irradiation was used.
Induction of caspase activation by curcumin/light
Using the Western blot technique we studied caspase activity as
an early marker of apoptosis. Initial experiments using curcumin
concentrations of 0.5 and 1 mg/ml showed only an activation of
caspases in VL-irradiated cells (figure 6). Thus, the subsequent
tests included incubation with 2 and 5 mg/ml curcumin and cell
lysis 4 hours after irradiation. The results presented in figure 6
show increasing signals of active caspases [11,12] and declining
signals of procaspase-3, an activation of initiator caspases-8 and -9,
as well as activation of the effector caspase-3. Remarkably, caspase
activation in UVA-irradiated cells was first noticeable at 2 mg/ml
and reached a maximum at a curcumin concentration of 5 mg/ml
(figure 6). An irradiation with VL induced a maximum signal at
2 mg/ml followed by a signal loss at 5 mg/ml - both corresponding
to previous results indicating a higher efficacy of this treatment.
Curcumin concentrations ranging from 0.5 to 5 mg/ml in
combination with VL definitely induce apoptosis in melanoma
cells. Several studies by others have highlighted the pro-apoptotic
properties of curcumin on different cell types. In contrast to our
Figure 5. DNA fragmentation in melanoma cells (A375 and G-
361) after treatment with curcumin and light: After incubation
with curcumin, cells were irradiated with UVA (gray bars), or
visible light (black bars), or were light-protected (white bars).
All values were referred to the untreated control as a 100% reference.
Every bar represents the average of 4 simultaneously determined
individual values; standard deviations are shown at the top. Significant
increase of DNA fragmentation of the treated cells is marked with *
(P!0.05).
doi:10.1371/journal.pone.0079748.g005
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ranging from 10 to 50 mM combined with a long-term incubation
of 8–72 hours had to be used [9,10,51]. Other studies demon-
strated that prior to apoptosis cell cycle was arrested at specific
transition points, particularly in the G2/M transition point, but
also at transition points G0/G1- and G1/S [4,26–29]. Our results
suggest that apoptosis induction occurs in melanoma cells after
treatment with low doses of curcumin combined with light
irradiation.
Intrinsic apoptotic pathway is predominant
Time-dependent lysis of cells displayed in figure 7, activated
caspase-9 was detected already 1.5–2 hours after VL-irradiation.
Contrary to some publications denoting caspase-8 [34,35] or
caspase-8 and -9 as leading initiator caspases in curcumin-induced
apoptosis [10,36,37], curcumin/light clearly induced the intrinsic
apoptosis pathway. Activation of caspase-8 became evident only
2 hours (and later) after irradiation which can be considered as a
secondary effect in enhancing the apoptotic signaling cascade [52].
Similar observations were made by Dujic et al. [12] using
keratinocytes. All these results also confirm the findings of
Laubach et al. [53], which excluded the initiation of an extrinsic
apoptosis via death receptors by the combined treatment with
curcumin and light irradiation.
Due to the rapid apoptotic reaction kinetics in melanoma cells
exposed to curcumin and light, the slight LDH release into the
medium mainly after treatment with curcumin/VL (figure 3) has
to be discussed. Since apoptotic cells in vivo increasingly detach
from adjacent tissue prior to phagocytosis by neighboring cells and
macrophages, in vitro apoptotic bodies undergo secondary
necrosis after ATP depletion and failure of ion pumps [46,50].
Kurbanov et al. [54] treated melanoma cells with TRAIL and
measured, in addition to apoptotic hallmarks, an increased release
of LDH after 24 hours, an effect not present 6 hours after
treatment. Thus it can be concluded that most probably,
secondary necrosis was present in some cases 24 hours after
treatment with curcumin/light.
In this study we have shown clearly that curcumin concentra-
tions of 0.25–5 mg/ml in combination with VL and of 0.5–5 mg/
ml in combination with UVA induce apoptosis in treated
melanoma cells. All results indicate a higher effectivity of the
treatment combined with visible light, which induces apoptosis in
up to 99% of all cells exposed to curcumin concentrations of 1–
2 mg/ml (2.7–5.4 mM). Compared to curcumin alone, a treatment
in combination with light irradiation offers several advantages
regarding a possible clinical use. Since the required curcumin
concentrations are low, oxidative effects can be excluded, which
have been documented in several studies for high curcumin
concentrations. Despite the extensive metabolism of curcumin, the
low serum concentrations needed for the combined treatment can
be achieved after oral application. When combined with light
irradiation, the time- and dose-dependency of the mode of action
of curcumin is amplified to a great extent and limited to the
irradiated area only. Synergistic effects can be expected from an
Figure 6. Caspase activation after treatment with curcumin (upper part: 0.5 and 1 mg/ml; lower part: 2 and 5 mg/ml) and light: A375
melanoma cells were incubated with curcumin and thereafter irradiated with UVA (middle lanes) or visible light (right lanes).
Controls remained light-protected (left lanes). After 6 hours cells were lysed. Detection of inactive (black arrows) and active (white arrows) formso f
caspase-8, caspase-9 and caspase-3 was carried out using the Western blot technique. b-actin-bands represent the loading control (dashed arrows).
doi:10.1371/journal.pone.0079748.g006
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of this study indicate that the combined treatment of curcumin
and light irradiation could be considered as an additional
therapeutic concept of malignant diseases.
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